Skip to content

Virtual reality analgesia for post laparoscopic pain

Investigating the effect of virtual reality on post laparoscopy pain scores in women

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618001398291
Enrollment
100
Registered
2018-08-20
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The following study will be a comparative open label randomised human pilot study for patients utilising a novel therapeutic modality technology- virtual reality (VR) - to assess its utility as an analgesic in acute pain post laparoscopy. The following pilot study is aimed at efficacy and will assess: • The effect of VR on pain scores after laparoscopy • The effect of VR on opiate analgesia requirements after laparoscopy • Patient feedback on device experience This will be achieved by comparing VR to routine care post laparoscopy. As such, the following study will aid in formulating evidence for utilising VR technology as an analgesia option post laparoscopy and potentially lay the foundations for a larger scale randomised controlled trial (RCT).

Interventions

Women in the comparator group will have a virtual reality headset attached between 10 degrees to 45-degree based on participant discretion. It will be administered for 3 x 10 minute segments seperated by 5 minutes in between for questions by the investigators or clinicians in the recovery area within 15 minutes of commencement of the laparoscopy. The virtual reality will be a through a pair of VR goggles with a VR video playing on it which will place the patient in an immersive environment that

Women in the comparator group will have a virtual reality headset attached between 10 degrees to 45-degree based on participant discretion. It will be administered for 3 x 10 minute segments seperated by 5 minutes in between for questions by the investigators or clinicians in the recovery area within 15 minutes of commencement of the laparoscopy. The virtual reality will be a through a pair of VR goggles with a VR video playing on it which will place the patient in an immersive environment that resembles an open field viewing stars in the sky.

Sponsors

Biorithm
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Women Undergoing laparoscopy for any indication with the Gynaecology Unit

Exclusion criteria

Conversion to laparotomy Chronic narcotic use / dependence Pregnancy Prior history of sensitivity to VR technology, motion sickness, vertigo, seizures, epilepsy and active nausea and vomiting Women below 18 years of age Patients with an intellectual or mental impairment People in existing dependent or unequal relationships with any member of the research team, the researcher(s) and/or the person undertaking the recruitment/consent process People highly dependent on medical care

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026